Skip to main content
Normal View

Medicinal Products

Dáil Éireann Debate, Wednesday - 22 May 2024

Wednesday, 22 May 2024

Questions (158)

Pádraig O'Sullivan

Question:

158. Deputy Pádraig O'Sullivan asked the Minister for Health if he will provide specific information on the current status of the pricing and reimbursement application for dostarlimab (jemperli) indicated as monotherapy for the treatment of adult patients with recurrent or advanced endometrial cancer; and if he will make a statement on the matter. [23054/24]

View answer

Written answers

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Top
Share